Amyloid- [beta] peptide induces temporal membrane biphasic changes in astrocytes through cytosolic phospholipase A₂

MOspace/Manakin Repository

Breadcrumbs Navigation

Amyloid- [beta] peptide induces temporal membrane biphasic changes in astrocytes through cytosolic phospholipase A₂

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/8096

[+] show full item record


Title: Amyloid- [beta] peptide induces temporal membrane biphasic changes in astrocytes through cytosolic phospholipase A₂
Author: Hicks, Jacob
Date: 2010
Publisher: University of Missouri--Columbia
Abstract: Oligomeric amyloid-[beta] peptide (A[beta]) is known to induce cytotoxic effects and damage cell functions in Alzheimer's disease. However, mechanisms underlying the effects of A[beta] on cell membranes have yet to be fully elucidated. In this study, A[beta] 1-42 (A[beta]₄₂) was shown to cause a temporal biphasic change in membranes of astrocytic DITNC cells using fluorescence microscopy of Laurdan. A[beta]₄₂ made astrocyte cell membranes become more molecularly-disordered after 30 minutes to 1 hour, transitioning to more molecularly-ordered after 3 hours. However, A[beta]₄₂ caused artificial vesicle membranes made of rat whole brain lipid extract to become more disordered only. The trend for more molecularly-ordered membranes in astrocytes was abrogated by either an NADPH oxidase inhibitor, apocynin, or an inhibitor of cytosolic phospholipase A₂ (cPLA₂), but not by an inhibitor of calcium-independent PLA2 (iPLA₂). Apocynin also suppressed the increased production of superoxide anions (O₂-) and phosphorylation of cPLA₂ induced by A[beta]₄₂ . In addition, hydrolyzed products of cPLA₂, arachidonic acid (AA), but not lysophosphatidylcholine (LPC) caused astrocyte membranes to become more molecularly-ordered. These results suggest (1) a direct interaction of A[beta]₄₂ with cell membranes making them more molecularly-disordered, and (2) A[beta]₄₂ indirectly makes membranes become more molecularly-ordered by triggering the signaling pathway involving NADPH oxidase and cPLA₂.
URI: http://hdl.handle.net/10355/8096
Other Identifiers: HicksJ-052110-T3709

This item appears in the following Collection(s)

[+] show full item record